360dx2d
MedMira Nabs Health Canada Approval for POC HIV, Syphilis Assay
The Nova Scotia-based firm's Multiplo Rapid TP/HIV Test is used to detect antibodies to HIV 1/2 and syphilis in a finger prick blood sample.
MedMira Reports Progress and Market Expansion
Medmira (TSE:MIR) has released an update.Don't Miss Our New Year's Offers:Discover the latest stocks recommended by top Wall Street analysts, ...
GlobalData on MSN7d
Health Canada approves MedMira’s rapid test for HIV and syphilis
The test enables healthcare professionals to identify HIV-1/2 and syphilis antibodies from a single finger prick sample.
MedMira, Inc.: MedMira Reports First Quarter Results FY2025
HALIFAX, NS / ACCESSWIRE / December 30, 2024 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter ended October 31, 2024.Corporate updateDuring Q1 FY2025, MedMi ...
Business Insider9d
MedMira Gains Health Canada Approval for Rapid Test
Medmira (TSE:MIR) has released an update. Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly expert ...
Finanznachrichten9d
MedMira, Inc.: MedMira receives Health Canada approval for its Multiplo Rapid Test for Syphilis and HIV
HALIFAX, NS / ACCESSWIRE / December 24, 2024 / MedMira Inc. (MedMira) (TSXV:MIR) announced today that it has received today, on December 24, 2024, the approval from Health Canada for its Multiplo ® ...